Cadisegliatin

Metabolites - Cadisegliatin is an oral glucokinase activator investigated for the treatment of type 2 diabetes by improving glucose sensing and enhancing insulin secretion and glycemic control. Reference standards of Cadisegliatin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

No Data Found